Cjc1295 without Dac
Product Details
Basic Info.
Model NO.:105
Name:Cjc1295 without Dac
CAS No:
Specification:2mg/Vial, 10vial/Kit
Mf:C165h269n47o46
MW:3647.28
Export Markets:Global
Additional Info.
Packing:Aluminum Foil Bag
Standard:USP
Origin:China
HS Code:3913900000
Production Capacity:100kilogram
Product Description
Product Description
Product name:High purity Cjc1295 Without Dac(2mg/vial,10vial/box)
Cas number:
Specification: 2mg/vial, 10vial/box
MOQ: 1box
Product Name:High purity Cjc1295 Without Dac(2mg/vial,10vial/box)
Cas number:
MW.: 3647.28
MF.: C165H269N47O46
Appearance: white freeze-dried powder
Sotre at: Cool dry place
Specification: 2mg/vial, 10vial/box
AppearanceWhite to off white powderConsistent
Purity(HPLC)≥95%96.02%
Water<6.0%5.20%
Acetic Acid3.0-8.0%6.95%
Trifluoroacetic Acid<0.25%0.20%
Peptide≥80%83.75%
MSConsistentConsistent
Payment method:Moneygram,Western Union,TT
Shipping method:Fedex,DHL,EMS or by SEA
Delivery time:within 3days after payment
Our process:
1)Contact me about what you need and your quantity, we will quoted you details.
2)Finish the payment.
3)We will arrange to send parcel out within 3days after payment, when tracking number updates,we will you.
4)Parcel delivered.
Email /> />Phone:
在线联系供应商
Other supplier products
 |
Argreline Acetate/Argireline | Product DetailsBasic Info.Model NO.:Synonyms:ArgirelineAssay:99%Packaging Details:Foil Bag or as RequiredDelivery Time:Within 24 Hours After Paymen... |
 |
||
 |
L-triiodothyronine | Product Details Basic Info. Model NO.:6893-02-3 Product Name:L-Triiodothyronine Other Name:L-Triiodothyronine CAS No.:6893-02-3 Assay:98% Appearanc... |
 |
Palmitoyl Tripeptide-1 | Product DetailsBasic Info.Model NO.:Palmitoyl Tripeptide-1Synonyms:Palmitoyl Tripeptide-1Heavy Metal:"10ppmPackage:as RequirmentsStorage:Keep in Co... |
 |
Cosmetic Peptide Acetyl Tetrapeptide-5 / Eyeseryl Winkey 1610 CAS No. | Basic Info.Model NO.:Type:Makeup SetsForm:PowderFunction:Foundation CosmeticsUsage:SkinUsed For:WomenAlias:Acetyl Tetrapeptide-5 / EyeserylCAS:Colo... |
